Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
The latest announcement is out from Forte Biosciences ( (FBRX) ).
Forte Biosciences, Inc. has reshuffled its board, appointing Richard Vincent and Shiv Kapoor as new Class II directors, following the resignations of Donald A. Williams and Lawrence Eichenfield. Both Vincent and Kapoor bring a wealth of experience in the biopharmaceutical sector, holding significant roles in various companies. Their appointments come as part of a strategic response to a legal action that the company faced, which also led to the creation of a Strategic Committee and the expiration of a stockholder rights agreement. The legal action has been dismissed as moot, with the company agreeing to pay $1.5 million in attorneys’ fees to settle the claims.
Find detailed analytics on FBRX stock on TipRanks’ Stock Analysis page.
